Eli Lilly and Company completes $1.4bn acquisition of POINT Biopharma

Pallavi Madhiraju- December 31, 2023 0

Eli Lilly and Company (NYSE: LLY) has announced the successful completion of its $1.4 billion acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a notable ... Read More

Eli Lilly announces $1.4bn acquisition of POINT Biopharma in radiopharmaceutical domain

Pallavi Madhiraju- October 3, 2023 0

Eli Lilly and Company (NYSE: LLY) is set to acquire POINT Biopharma Global, Inc. (NASDAQ: PNT), a leading radiopharmaceutical firm, marking a significant leap in ... Read More